JPMorgan BetaBuilders Europe (BBEU)
BBEU price chart
BBEU fund facts
Returns and risk
Cost: expense ratio
On $10,000 invested that is about $9 a year in fund costs, taken out of the fund's assets.
Income: distributions
BBEU top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | ASML Holding NV | 4.58% |
| 2 | HSBC Holdings plc | 2.62% |
| 3 | Roche Holding AG | 2.16% |
| 4 | Novartis AG | 2.14% |
| 5 | AstraZeneca plc | 1.89% |
| 6 | Shell plc | 1.83% |
| 7 | Nestle SA | 1.78% |
| 8 | JPMorgan Securities Lending Money Market Fund | 1.78% |
| 9 | Siemens AG | 1.68% |
| 10 | Banco Santander SA | 1.46% |
Similar International ETFs
DIHP Dimensional International High...0.27% fee · +12.9% 1y CWI SPDR MSCI ACWI ex-US0.30% fee · +14.6% 1y QINT American Century Quality Diver...0.34% fee · +15.4% 1y MFSI MFS Active International0.59% fee · +11.6% 1y HEFA iShares Currency Hedged MSCI E...0.35% fee · +18.7% 1y BBAX JPMorgan BetaBuilders Develope...0.19% fee · +14.2% 1y All international ETFs →BBEU: frequently asked questions
What is BBEU?
BBEU is the JPMorgan BetaBuilders Europe ETF, issued by JPMorgan, listed on BATS. By our rules it is classed as "International". Its latest SEC filing lists 362 holdings.
What is the expense ratio of BBEU?
BBEU charges 0.09% a year, according to its prospectus filed with the SEC on 25 Feb 2026. On $10,000 that is about $9 a year in fund costs.
Does BBEU pay dividends?
Yes. BBEU paid 2.29 per share over the last 12 months, quarterly, a trailing yield of 3.03% on today's price. The latest ex-dividend date was 22 Sep 2026.
What does BBEU hold?
The largest holdings in the latest SEC filing are ASML Holding NV (4.6%), HSBC Holdings plc (2.6%), Roche Holding AG (2.2%). The top 10 together make up 21.9% of the fund.
How has BBEU performed?
Total return including distributions to 22 Oct 2026: 1 year +10.6%, 3 years +19.2% a year, 5 years +8.7% a year. Past performance does not guarantee future results.
Where the numbers come from
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.